CD44 and ovarian cancer: Thus, CD117+/CD44+ ovarian cancer cells were shown to have a higher basal autophagy than the CD117− counterpart; inhibition of this pathway by cloroquine treatment inhibits the growth and the survival of ovarian cancer spheroids and their tumorigenic activity in vivo [244].